<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="168054">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00909714</url>
  </required_header>
  <id_info>
    <org_study_id>NETS Trial</org_study_id>
    <nct_id>NCT00909714</nct_id>
  </id_info>
  <brief_title>Neuroregeneration Enhanced by Transcranial Direct Current Stimulation (TDCS) in Stroke</brief_title>
  <acronym>NETS</acronym>
  <official_title>Neuroregeneration Enhanced by TDCS in Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitätsklinikum Hamburg-Eppendorf</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitätsklinikum Hamburg-Eppendorf</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Testing the hypothesis that non-invasive brain stimulation by transcranial direct current
      stimulation (tDCS) combined with functional training in the subacute phase of first-ever
      stroke will enhance functional regeneration compared with a Placebo intervention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Stroke is the leading cause of long-term disability, which significantly impairs the
      economic and social life of patients and society. Every year 200 000 to 250 000 patients
      suffer a stroke in Germany. Only a small number of the stroke survivors recover to a degree
      that allows them to return into their professional and private life. Despite significant
      efforts to develop novel and efficient treatment strategies the level of functional
      regeneration is still not satisfying. Thus, the development of innovative and effective
      treatment strategies will have a major impact for the patients' life, the society and the
      public health system.

      Within the proposed project an innovative, non-invasive and cost effective interventional
      strategy, based on the combination of a specific rehabilitative training and brain
      stimulation by transcranial direct current stimulation (tDCS), will be used to enhance
      functional regeneration in stroke patients. The intervention will be applied in an early
      stage in which plasticity, cortical reorganization and functional improvement is most
      pronounced. We hypothesize that the combination of anodal tDCS delivered to the motor cortex
      of the affected hemisphere combined with training over a period of two weeks in the subacute
      stage after stroke will significantly enhance cortical plasticity, functional regeneration
      and long-term outcome determined by clinical and functional outcome measures compared with
      Placebo stimulation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Upper Extremity Fugl-Meyer-Assessment (UEFMA)</measure>
    <time_frame>12 months after the intervention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Jebsen-Taylor Test (JTT), Action Research Arm Test (ARAT), Nine Hole Peg Test (NHPT), Stroke Impact Scale (SIS), UEFMA</measure>
    <time_frame>12 months after the intervention (day11, 40, 100, 190 after intervention)</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Stroke</condition>
  <arm_group>
    <arm_group_label>tDCS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>DC-Stimulator to apply tDCS + Training</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham tDCS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>DC-Stimulator to apply Sham tDCS (Placebo) + Training</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>DC-Stimulator to apply tDCS or Sham tDCS</intervention_name>
    <description>Anodal tDCS (20 minutes) or Sham stimulation will be applied once a day in combination with standardized upper extremity rehabilitative training</description>
    <arm_group_label>tDCS</arm_group_label>
    <arm_group_label>Sham tDCS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subacute stroke patients (5-21 days after stroke, age&gt;18 years) with thromboembolic
             non-hemorrhagic subcortical or cortical first-ever strokes will be included. Moderate
             to moderately severe upper-extremity hemiparesis, defined as an Upper Extremity
             Fugl-Meyer score (UEFMA) between 28 and 50 (inclusive).

        Exclusion Criteria:

          -  more than one stroke

          -  progressive stroke

          -  completely lesioned hand knob area of M1affected or cerebellar lesions

          -  history of severe alcohol or drug abuse, psychiatric illnesses like severe
             depression, poor motivational capacity, or severe language disturbances, or with
             serious cognitive deficits

          -  severe uncontrolled medical problems

          -  rheumatological or traumatic diseases affecting the upper extremities

          -  other neurological diseases

          -  severe microangiopathy, polyneuropathy, ischemic peripheral disease

          -  pregnancy

          -  contraindication for MRI or TMS
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian Gerloff, Prof. Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Neurology, University Medical Center Hamburg-Eppendorf</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Christian Gerloff, Prof. Dr.</last_name>
    <phone>+49(0)40 741053770</phone>
    <email>gerloff@uke.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Robert Schulz, Dr.</last_name>
    <phone>+49(0)40 741053770</phone>
    <email>r.schulz@uke.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Neurologische Klinik Bad Aibling</name>
      <address>
        <city>Bad Aibling</city>
        <zip>83043</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jürgen Dressnandt, Dr.</last_name>
      <phone>+49(0)80619031510</phone>
      <email>jdressnandt@Schoen-Kliniken.de</email>
    </contact>
    <contact_backup>
      <last_name>Barbara Schäpers</last_name>
      <phone>+49(0)80619031952</phone>
      <email>bschaepers@schoen-kliniken.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Moritz-Klinik</name>
      <address>
        <city>Bad Klosterlausnitz</city>
        <zip>07639</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Farsin Hamzei, Prof. Dr.</last_name>
      <phone>+49(0)3660149470</phone>
      <email>farsin.hamzei@moritz-klinik.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Neurologisches Zentrum Segeberger Kliniken</name>
      <address>
        <city>Bad Segeberg</city>
        <zip>23795</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Manuel Valdueza, Prof. Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Björn Hauptmann, Dr.</last_name>
      <phone>+49(0)45518026853</phone>
      <email>bjoern.hauptmann@segebergerkliniken.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>MEDIAN Klinik Berlin-Kladow</name>
      <address>
        <city>Berlin</city>
        <zip>14089</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Dohle, Dr.</last_name>
      <phone>+49(0)3036503102</phone>
      <email>christian.dohle@median-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Medical Center Hamburg Eppendorf (UKE)</name>
      <address>
        <city>Hamburg</city>
        <zip>20246</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Schulz, Dr.</last_name>
      <phone>+49(0)40741053770</phone>
      <email>r.schulz@uke.de</email>
    </contact>
    <contact_backup>
      <last_name>Julia Hoppe, Dr.</last_name>
      <phone>+49(0)40741053770</phone>
      <email>j.hoppe@uke.de</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Medical Center Heidelberg</name>
      <address>
        <city>Heidelberg</city>
        <zip>69120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Gutschalk, Prof. Dr.</last_name>
      <phone>+49(0)6221567504</phone>
      <email>Alexander.Gutschalk@med.uni-heidelberg.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>HELIOS Klinik Kipfenberg</name>
      <address>
        <city>Kipfenberg</city>
        <zip>85110</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dennis Nowak, Prof. Dr.</last_name>
      <phone>+49(0)8465175102</phone>
      <email>dennis.nowak@helios-kliniken.de</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fondazione Santa Lucia</name>
      <address>
        <city>Rome</city>
        <zip>00179</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giacomo Koch, Prof. Dr.</last_name>
      <phone>+39(0)651501181</phone>
      <email>giakoch@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
    <country>Italy</country>
  </location_countries>
  <removed_countries>
    <country>Austria</country>
    <country>France</country>
    <country>Switzerland</country>
  </removed_countries>
  <reference>
    <citation>Hummel F, Celnik P, Giraux P, Floel A, Wu WH, Gerloff C, Cohen LG. Effects of non-invasive cortical stimulation on skilled motor function in chronic stroke. Brain. 2005 Mar;128(Pt 3):490-9. Epub 2005 Jan 5.</citation>
    <PMID>15634731</PMID>
  </reference>
  <reference>
    <citation>Wessel MJ, Zimerman M, Timmermann JE, Heise KF, Gerloff C, Hummel FC. Enhancing Consolidation of a New Temporal Motor Skill by Cerebellar Noninvasive Stimulation. Cereb Cortex. 2016 Apr;26(4):1660-7. doi: 10.1093/cercor/bhu335. Epub 2015 Jan 20.</citation>
    <PMID>25604611</PMID>
  </reference>
  <reference>
    <citation>Schulz R, Gerloff C, Hummel FC. Non-invasive brain stimulation in neurological diseases. Neuropharmacology. 2013 Jan;64:579-87. doi: 10.1016/j.neuropharm.2012.05.016. Epub 2012 Jun 9. Review.</citation>
    <PMID>22687520</PMID>
  </reference>
  <reference>
    <citation>Zimerman M, Heise KF, Hoppe J, Cohen LG, Gerloff C, Hummel FC. Modulation of training by single-session transcranial direct current stimulation to the intact motor cortex enhances motor skill acquisition of the paretic hand. Stroke. 2012 Aug;43(8):2185-91. doi: 10.1161/STROKEAHA.111.645382. Epub 2012 May 22.</citation>
    <PMID>22618381</PMID>
  </reference>
  <reference>
    <citation>Hummel FC, Celnik P, Pascual-Leone A, Fregni F, Byblow WD, Buetefisch CM, Rothwell J, Cohen LG, Gerloff C. Controversy: Noninvasive and invasive cortical stimulation show efficacy in treating stroke patients. Brain Stimul. 2008 Oct;1(4):370-82. doi: 10.1016/j.brs.2008.09.003. Epub 2008 Oct 9. Review.</citation>
    <PMID>20633395</PMID>
  </reference>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 28, 2016</lastchanged_date>
  <firstreceived_date>May 12, 2009</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>stroke</keyword>
  <keyword>non-invasive cortical stimulation</keyword>
  <keyword>motor recovery</keyword>
  <keyword>cortical plasticity</keyword>
  <keyword>TDCS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
